EXETF (Extendicare) Long-Term Debt: $222 Mil (As of Mar. 2026)


EXETF Extendicare Inc EXETF
76 GF Score
Price $24.85
GF Value $9.81
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Extendicare Long-Term Debt?

Extendicare EXETF +0.49% 76 Long-Term Debt is $222 Mil as of Mar. 2026. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $9.81 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Extendicare's Long-Term Debt for the quarter that ended in Mar. 2026 was $222 Mil.

Extendicare's quarterly Long-Term Debt declined from Sep. 2025 ($229 Mil) to Dec. 2025 ($225 Mil) and declined from Dec. 2025 ($225 Mil) to Mar. 2026 ($222 Mil).

Extendicare's annual Long-Term Debt declined from Dec. 2023 ($235 Mil) to Dec. 2024 ($183 Mil) but then increased from Dec. 2024 ($183 Mil) to Dec. 2025 ($225 Mil).

Extendicare  (OTCPK:EXETF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Extendicare Long-Term Debt Related Terms

Extendicare Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Extendicare's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Extendicare Long-Term Debt Chart

Extendicare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 361.93 268.48 234.52 183.47 224.98

Extendicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 188.31 195.53 229.26 224.98 222.32
EXETF
76GF Score
Extendicare Inc EXETF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $222 Mil mean?
Extendicare (EXETF) has a Long-Term Debt of $222 Mil as of Mar. 2026.
Is Extendicare's Long-Term Debt too high?
Extendicare's current Long-Term Debt is $222 Mil. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Long-Term Debt compare to HCA and THC?
Extendicare's Long-Term Debt of $222 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Extendicare's current Long-Term Debt is $222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $9.81, compared to a current price of $24.85 — trading 153.3% above its estimated fair value. The current Long-Term Debt is $222 Mil. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Extendicare (EXETF), the current Long-Term Debt is $222 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Extendicare (EXETF) Overvalued in 2026?

Based on GuruFocus' analysis, Extendicare stock appears to be overvalued. The current stock price of $24.85 is trading 153.3% above its estimated GF Value™ of $9.81. GuruFocus considers Extendicare to be Significantly Overvalued.

Key valuation signals for EXETF:

  • Long-Term Debt: $222 Mil
  • GF Value™: $9.81 vs. price of $24.85 (153.3% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Extendicare Business Description

Address 3000 Steeles Avenue East, Suite 400, Markham, ON, CAN, L3R 4T9
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score

Get the complete analysis for EXETF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.85
Price
$9.81
GF Value